Upregulation of lncRNA H19 promotes nasopharyngeal carcinoma proliferation and metastasis in let-7 dependent manner
Source abstract
Abstract
The aim of this study is to analyse the expression status of long non-coding RNA (lncRNA) H19 in nasopharyngeal carcinoma and to unravel its oncogenic properties at molecular level. The abundance of H19, let-7a, b, g, i and HRAS was quantified by real-time PCR. Cell viability was measured by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide method. Cell proliferation was evaluated by the cell counting. Cell migration and cell invasion were determined using transwell chamber and scattering colony formation. Tumour progression was monitored in xenograft tumour model and tail vein injection was adopted for lung metastasis assessment. Luciferase reporter assay was employed to interrogate the potential regulatory action of let-7 genes on H19 expression. The endogenous HRAS protein was quantified by western blotting. H19 was aberrantly over-expression in nasopharyngeal carcinoma, which intimately associated with poorer prognosis. H19-deficency significantly inhibited cell viability and suppressed cell proliferation. Furthermore, both migrative and invasive capacity were compromised by H19 knockdown. H19-silencing remarkably delayed xenograft tumour progression and lung metastasis. Mechanistically, H19 competitively sponged let-7 genes and therefore up-regulated HRAS, which consequently contributed to its oncogenic activity in nasopharyngeal carcinomas. Our study uncovered the oncogenic properties of H19 in nasopharyngeal carcinoma and highlighted the H19-let-7-HRAS signalling axis underlying the incidence and metastasis of this disease.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Cancer-related molecular mechanisms research · RNA modifications and cancer · RNA Research and Splicing
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
The First Affiliated Hospital of Zhengzhou University
Jinan Central Hospital Affiliated to Shandong University
References (31)
Show source-provided references
1. 10.1016/S0140-6736(15)00055-010.1016/S0140-6736(15)00055-0 ↗
2. Wei KR, Zheng RS, Zhang SW, et al. Nasopharyngeal carcinoma incidence and mortality in China in 2010. Chin J Cancer. 2014;33:381–387.
3. 10.1016/j.semcancer.2012.01.00410.1016/j.semcancer.2012.01.004 ↗
4. 10.1158/1055-9965.EPI-16-014910.1158/1055-9965.EPI-16-0149 ↗
5. 10.1016/S1470-2045(15)70126-910.1016/S1470-2045(15)70126-9 ↗
6. 10.1038/nrg252110.1038/nrg2521 ↗
7. 10.5483/BMBRep.2012.45.11.22710.5483/BMBRep.2012.45.11.227 ↗
8. 10.18632/oncotarget.405710.18632/oncotarget.4057 ↗
9. 10.1007/s12032-015-0673-010.1007/s12032-015-0673-0 ↗
10. 10.1371/journal.pone.011067410.1371/journal.pone.0110674 ↗
11. 10.1007/s00432-018-2582-z10.1007/s00432-018-2582-z ↗
12. 10.1093/abbs/gmx10510.1093/abbs/gmx105 ↗
13. 10.1159/00048002810.1159/000480028 ↗
14. 10.1002/ijc.1092610.1002/ijc.10926 ↗
15. 10.1016/j.bbrc.2016.03.15010.1016/j.bbrc.2016.03.150 ↗
16. 10.18632/oncotarget.191310.18632/oncotarget.1913 ↗
17. Yang W, Ning N, Jin X. The lncRNA H19 promotes cell proliferation by competitively binding to miR-200a and derepressing β-catenin expression in colorectal cancer. Biomed Res Int. 2017;2017:2767484.
18. 10.1016/j.ygeno.2008.01.00710.1016/j.ygeno.2008.01.007 ↗
19. 10.1136/jmedgenet-2015-10333410.1136/jmedgenet-2015-103334 ↗
20. 10.1002/jbt.2193310.1002/jbt.21933 ↗
21. 10.1126/scisignal.aak955710.1126/scisignal.aak9557 ↗
22. 10.3892/ijo.2017.394110.3892/ijo.2017.3941 ↗
23. 10.1002/1873-3468.1217110.1002/1873-3468.12171 ↗
24. 10.18632/oncotarget.415410.18632/oncotarget.4154 ↗
25. 10.1016/j.bbamcr.2017.08.00110.1016/j.bbamcr.2017.08.001 ↗
26. 10.3892/mmr.2017.702910.3892/mmr.2017.7029 ↗
27. 10.1111/febs.1374110.1111/febs.13741 ↗
28. Ge YJ, Xie XY, Yang B, et al. VIGILIN involves in regulation of imprinting gene IGF2 and H19 in human hepatocellular carcinoma cell. Sichuan Da Xue Xue Bao Yi Xue Ban. 2009;40(5):770–774.
29. 10.1210/jcem.87.3.833110.1210/jcem.87.3.8331 ↗
30. 10.1002/jcp.2611910.1002/jcp.26119 ↗
31. 10.1186/s13045-016-0348-010.1186/s13045-016-0348-0 ↗